ArticlePloS one2026
Bayesian model discovery for reverse-engineering biochemical networks from data.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reverse engineering gene regulatory networks from gene expression data is a challenging inference task. A related problem in computational systems biology is identification of signalling networks that perform particular functions, such as adaptation. Indeed, for many research questions, there is an ongoing need for efficient inference algorithms that can identify the simplest model, from among a larger set of inter-related models, that best explains empirical observations. To this end, we introduce Sparse Likelihood-free Inference using Gibbs sampling (SLInG), a Bayesian sparse likelihood-free inference method. SLInG provides an efficient sampling method for Approximate Bayesian Computation with sparsity-inducing hierarchical priors that is widely applicable for any simulation-based model discovery task. We first apply SLInG to linear sparse regression problem using a classic dataset, before focusing on applications to biochemical network model discovery. We demonstrate that SLInG can reverse engineer stochastic gene regulatory networks from single-cell data with high accuracy, outperforming state-of-the-art correlation-based methods. Furthermore, we show that SLInG can successfully identify signalling networks that execute adaptation. Sparse hierarchical Bayesian inference thus provides a versatile and powerful tool for model discovery in systems biology and beyond.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.